Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Onco-Innovations Ltd. ( (TSE:ONCO) ) has shared an update.
Onco-Innovations Limited applauds the Lundin Cancer Fund for its significant $4 million donation to the Canadian Cancer Society, which will establish a pan-Canadian glioblastoma research program. This contribution aims to accelerate research efforts for new treatment options for glioblastoma, one of the most aggressive brain cancers, and marks the largest philanthropic gift for this cause. In addition, Onco-Innovations has extended its engagement with MCS Market Communication Service GmbH for online marketing services, emphasizing its commitment to advancing cancer research and patient outcomes through innovative therapies.
More about Onco-Innovations Ltd.
Onco-Innovations Limited is a Canadian-based company specializing in oncology, dedicated to cancer research and treatment. The company focuses on pioneering research and innovative solutions to prevent and cure cancer. It has secured an exclusive worldwide license for patented technology targeting solid tumors, aiming to set new standards in cancer treatment.
YTD Price Performance: 143.53%
Average Trading Volume: 398,083
See more data about ONCO stock on TipRanks’ Stock Analysis page.
